Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[ADPKD and IPMN: Mere Coincidence or Double Trouble?].
Kola K, De Rosa LI, Catania M, Brambilla Pisoni M, Tunesi F, Farinone S, Petrone M, Manunta P, Vezzoli G, Sciarrone Alibrandi MT. Kola K, et al. Among authors: manunta p. G Ital Nefrol. 2024 Aug 26;41(4):2024-vol4. doi: 10.69097/41-04-2024-05. G Ital Nefrol. 2024. PMID: 39243410 Review. Italian.
Beyond the kidneys: investigating airway involvement in autosomal dominant polycystic kidney disease through nasal nitric oxide profiling : A transversal single-center observational study.
De Rosa LI, Vespa M, Catania M, Kola K, Bucci R, Mancassola G, Carrera P, Manunta P, Vezzoli G, Sciarrone Alibrandi MT. De Rosa LI, et al. Among authors: manunta p. J Nephrol. 2024 Oct 22. doi: 10.1007/s40620-024-02116-1. Online ahead of print. J Nephrol. 2024. PMID: 39433723 No abstract available.
Hypertension in hemodialysis patients.
Querques M, Manunta P. Querques M, et al. Among authors: manunta p. Minerva Urol Nefrol. 2010 Mar;62(1):41-50. Minerva Urol Nefrol. 2010. PMID: 20424569 Review.
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial.
Ruggenenti P, Trillini M, P Barlovic D, Cortinovis M, Pisani A, Parvanova A, Iliev IP, Ruggiero B, Rota S, Aparicio MC, Perna A, Peraro F, Diadei O, Gaspari F, Carrara F, Stucchi N, Martinetti D, Janez A, Gregoric N, Riccio E, Bossi AC, Trevisan R, Manunta P, Battaglia G, David S, Aucella F, Belviso A, Satta A, Remuzzi G; VALID Study Organization. Ruggenenti P, et al. Among authors: p barlovic d, manunta p. Diabetes Obes Metab. 2019 May;21(5):1177-1190. doi: 10.1111/dom.13639. Epub 2019 Feb 22. Diabetes Obes Metab. 2019. PMID: 30793466 Clinical Trial.
205 results